13F Filings History of Regal Partners Ltd
- Latest 13F filing
- Q2 2026 - 14 Aug 2026
- Latest reported 13F value
- $1,811,326,350
- Largest 13F holdings
-
NEM APO BAC RPRX SCHW SNY FCX TECK WYNN DIS UNP WFC
+8 more
TFC SHAZ V HBM GROY BTG HCA AA - Form 13F summary
-
- Regal Partners Ltd Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Regal Partners Ltd reported 122 equity holdings with a total reported market value of $1,811,326,350 for Q2 2026. Top reported holdings included NEM, APO, BAC, RPRX, and SCHW.
- Manager signature
- Faiz Farrukh - Head of Compliance
- Manager location
- Sydney
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Regal Partners Ltd with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2026
Latest value
$1,811,326,350
Quarter delta
-$28,091,819
Accepted
13 Aug 2026, 21:49
Rows shown
1-25 of 51
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 122 | $1,811,326,350 | +$350,041,248 | -$421,480,879 | -$71,439,631 | NEM, APO, BAC, RPRX, SCHW | 13F-HR | 13 Aug 2026, 21:49 |
| Q1 2026 | 106 | $1,839,418,169 | +$331,978,182 | -$236,017,343 | +$95,960,839 | NEM, FCX, APO, TECK, BAC | 13F-HR | 15 May 2026, 09:23 |
| Q4 2025 | 97 | $1,734,313,092 | +$381,992,436 | -$194,326,727 | +$187,665,709 | NEM, TECK, FCX, APO, BAC | 13F-HR | 17 Feb 2026, 20:49 |
| Q3 2025 | 86 | $1,397,801,512 | +$228,134,305 | -$186,395,236 | +$41,739,069 | NEM, TECK, BAC, WYNN, FCX | 13F-HR | 12 Nov 2025, 21:55 |
| Q2 2025 | 76 | $1,183,328,939 | +$196,026,615 | -$108,807,557 | +$87,219,058 | FCX, TECK, NEM, WYNN, BAC | 13F-HR | 04 Aug 2025, 21:25 |
| Q1 2025 | 49 | $976,414,231 | +$139,531,103 | -$143,483,619 | -$3,952,516 | NEM, TECK, WYNN, BAC, FCX | 13F-HR | 12 May 2025, 19:52 |
| Q4 2024 | 56 | $987,672,262 | +$140,606,025 | -$256,782,002 | -$116,175,977 | TECK, BAC, APO, WYNN, FCX | 13F-HR | 14 Feb 2025, 17:12 |
| Q3 2024 | 48 | $1,131,464,315 | +$192,753,984 | -$91,753,977 | +$101,000,007 | TECK, FCX, APO, WYNN, BAC | 13F-HR | 05 Nov 2024, 19:51 |
| Q2 2024 | 46 | $965,461,662 | +$200,829,020 | -$238,094,756 | -$37,265,736 | TECK, APO, BAC, WYNN, WFC | 13F-HR | 01 Aug 2024, 20:11 |
| Q1 2024 | 49 | $994,883,047 | +$166,390,250 | -$213,278,870 | -$46,888,620 | TECK, APO, FCX, BAC, WYNN | Restatement | 14 May 2024, 19:27 |
| Q4 2023 | 40 | $940,245,322 | +$609,670,944 | -$151,987,883 | +$457,683,061 | TECK, FCX, APO, BAC, WYNN | Restatement | 14 May 2024, 19:29 |
| Q3 2023 | 40 | $448,027,678 | +$159,228,933 | -$159,175,151 | +$53,782 | KVUE, TECK, CME, GEHC, AMZN | 13F-HR | 13 Nov 2023, 18:52 |
| Q2 2023 | 33 | $461,373,368 | +$120,382,349 | -$199,219,783 | -$78,837,434 | CME, AMZN, GEHC, SLB, PINS | 13F-HR | 14 Aug 2023, 19:34 |
| Q1 2023 | 35 | $512,866,517 | +$139,177,561 | -$112,475,212 | +$26,702,349 | AMZN, CME, DIS, GEHC, PINS | 13F-HR | 15 May 2023, 17:29 |
| Q4 2022 | 37 | $427,931,794 | +$73,269,701 | -$95,272,958 | -$22,003,257 | AMZN, CME, PINS, MA, DIS | Restatement | 15 Aug 2023, 19:24 |
| Q3 2022 | 34 | $476,581,000 | +$46,864,356 | -$135,707,401 | -$88,843,045 | AMZN, CME, MA, PINS, SLB | Restatement | 15 Aug 2023, 19:20 |
| Q2 2022 | 32 | $587,602,000 | +$184,806,813 | -$42,308,094 | +$142,498,719 | AMZN, CME, MA, PINS, TWTR | Restatement | 09 Sep 2022, 12:38 |
| Q1 2022 | 17 | $772,420,000 | +$86,169,648 | -$60,328,932 | +$25,840,716 | AMZN, CME, MA, XM, PINS | 13F-HR | 16 May 2022, 10:01 |
| Q4 2021 | 14 | $833,665,000 | +$34,949,232 | -$59,497,744 | -$24,548,512 | AMZN, MA, CME, PINS, XM | 13F-HR | 14 Feb 2022, 16:21 |
| Q3 2021 | 14 | $910,267,000 | +$11,756,704 | -$230,807,469 | -$219,050,765 | AMZN, MA, PINS, CME, XM | 13F-HR | 15 Nov 2021, 15:01 |
| Q2 2021 | 18 | $1,263,685,000 | +$252,281,977 | -$199,137,155 | +$53,144,822 | AMZN, PINS, MA, CME, OTIS | 13F-HR | 16 Aug 2021, 10:51 |
| Q1 2021 | 16 | $1,129,307,000 | +$177,678,734 | -$45,374,325 | +$132,304,409 | AMZN, MA, PINS, CME, OTIS | 13F-HR | 14 May 2021, 19:19 |
| Q4 2020 | 13 | $968,949,000 | +$151,317,106 | -$46,615,790 | +$104,701,316 | AMZN, MA, PINS, CME, OTIS | 13F-HR | 16 Feb 2021, 10:41 |
| Q3 2020 | 7 | $756,505,000 | +$128,551,960 | -$297,515,417 | -$168,963,457 | AMZN, MA, CME, PINS, OTIS | 13F-HR | 16 Nov 2020, 13:47 |
| Q2 2020 | 9 | $851,242,000 | +$59,064,000 | -$261,986,886 | -$202,922,886 | AMZN, MA, LIN, CME, CL | 13F-HR | 14 Aug 2020, 10:16 |